XPHOZAH 10 mg, XPHOZAH 20 mg, XPHOZAH 30 mg

What is this medication? Xphozah, which contains the active ingredient tenapanor, is a prescription medication used to lower high levels of phosphorus in the blood of adults with chronic kidney disease who are undergoing dialysis. It is specifically indicated for patients who have not responded sufficiently to traditional phosphate binders or who cannot tolerate those treatments. Maintaining phosphorus within a healthy range is important for patients on dialysis to help prevent long-term complications related to bone and heart health. This medication functions as a sodium-hydrogen exchanger 3 inhibitor, representing a different approach compared to traditional binders. Instead of binding to phosphorus in the digestive tract to prevent absorption, Xphozah works by blocking the primary pathway that the intestines use to absorb phosphate into the bloodstream. It is available in 20 mg and 30 mg tablets and is often used as an add-on therapy to help patients achieve their target phosphorus goals more effectively.